1.	Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DMS30203R, NCT00039780
2.	Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DMS32212R, NCT00966914
3.	Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000350089, U10CA031946, CALGB-30303, NCT00077311
4.	Phase I Study of Dimesna in Patients with Solid Tumor Undergoing Treatment with Cisplatin and Paclitaxel Phase: Phase I Type: Natural history/Epidemiology, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: RPCI-DS-9739, BIONUM-BNP7787IV101, NCI-G98-1478, NCT00003569